Dual-Chamber Implanted Pacemaker Detects Cardiac Movement
By HospiMedica International staff writers Posted on 03 Feb 2020 |

Image: The Micra AV leadless pacemaker with internal atrial sensing algorithms (Photo courtesy of Medtronic)
A miniaturized device offers patients with AV block an advanced leadless technology at one-tenth the size of a traditional pacemaker.
The Medtronic (Dublin, Ireland) Micra AV provides atrioventricular (AV) synchrony capabilities, thanks to a built-in three dimensional (3D) accelerometer that can sense the back and forth movement of the heart, and can therefore coordinate pacing of the ventricle that it is synchronized with the contractions of the atrium. The Micra AV pacemaker is identical in size and shape with the original Micra Transcatheter Pacing System (TPS), with an estimated 12-year battery life, and is approved for full body 1.5 and 3 Tesla scans magnetic resonance imaging (MRI) scans.
Micra AV is delivered via a minimally invasive percutaneous catheter through the femoral vein and is then positioned inside the right ventricle, directly attached to the heart via small nitinol tines that hold it and the electrodes in place; it can be repeatedly repositioned to make sure that heart activity and low electrical thresholds are at optimal levels. Once positioned, the device responds to patients' activity levels by automatically adjusting therapy. And as it does not require a subcutaneous surgical pocket to be created, potential complications are eliminated.
“Since revolutionizing medicine with the first battery-powered cardiac pacemakers, Medtronic has continued to develop pioneering pacing technologies, culminating in the first miniaturized, leadless pacing portfolio for physicians and their patients,” said Rob Kowal, MD, PhD, of the Vascular Group at Medtronic. “The introduction of Micra AV reinvents our own innovation, bringing the many benefits of leadless pacemakers to more patients.”
“With the approval of Micra AV, more pacemaker patients qualify for a new treatment option that offers the advantages of leadless pacing, including a minimally invasive implant procedure and a cosmetically invisible device,” said cardiac electrophysiologist Larry Chinitz, MD, director of the NYU Langone Heart Rhythm Center (New York, NY, USA). “Although complications with traditional pacemakers are infrequent, when they occur, they’re expensive to treat and can be invasive for the patient. Real-world use of Micra has shown a 63% reduction in major complications compared to traditional pacemakers.”
Within the right atrium of a normal heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (SA node) to the ventricles (AV node). In the presence of an AV block the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed. If the heart block occurs in the fetus or newborn, the condition is known as congenital heart block.
Related Links:
Medtronic
The Medtronic (Dublin, Ireland) Micra AV provides atrioventricular (AV) synchrony capabilities, thanks to a built-in three dimensional (3D) accelerometer that can sense the back and forth movement of the heart, and can therefore coordinate pacing of the ventricle that it is synchronized with the contractions of the atrium. The Micra AV pacemaker is identical in size and shape with the original Micra Transcatheter Pacing System (TPS), with an estimated 12-year battery life, and is approved for full body 1.5 and 3 Tesla scans magnetic resonance imaging (MRI) scans.
Micra AV is delivered via a minimally invasive percutaneous catheter through the femoral vein and is then positioned inside the right ventricle, directly attached to the heart via small nitinol tines that hold it and the electrodes in place; it can be repeatedly repositioned to make sure that heart activity and low electrical thresholds are at optimal levels. Once positioned, the device responds to patients' activity levels by automatically adjusting therapy. And as it does not require a subcutaneous surgical pocket to be created, potential complications are eliminated.
“Since revolutionizing medicine with the first battery-powered cardiac pacemakers, Medtronic has continued to develop pioneering pacing technologies, culminating in the first miniaturized, leadless pacing portfolio for physicians and their patients,” said Rob Kowal, MD, PhD, of the Vascular Group at Medtronic. “The introduction of Micra AV reinvents our own innovation, bringing the many benefits of leadless pacemakers to more patients.”
“With the approval of Micra AV, more pacemaker patients qualify for a new treatment option that offers the advantages of leadless pacing, including a minimally invasive implant procedure and a cosmetically invisible device,” said cardiac electrophysiologist Larry Chinitz, MD, director of the NYU Langone Heart Rhythm Center (New York, NY, USA). “Although complications with traditional pacemakers are infrequent, when they occur, they’re expensive to treat and can be invasive for the patient. Real-world use of Micra has shown a 63% reduction in major complications compared to traditional pacemakers.”
Within the right atrium of a normal heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (SA node) to the ventricles (AV node). In the presence of an AV block the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed. If the heart block occurs in the fetus or newborn, the condition is known as congenital heart block.
Related Links:
Medtronic
Latest Critical Care News
- Novel Coating Significantly Extends Longevity of Implantable Biosensors
- Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
- New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
- Battery-Powered Wearable Device Monitors Joint Pain
- Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more